
Voligraf 0.3mg Tablet
Marketer
GRAF Laboratories Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Voligraf 0.3mg Tablet
Diabex 0.3mg tablets are prescribed for managing type 2 diabetes. This medication assists in regulating elevated post-prandial blood glucose. It's indicated when dietary modifications and other comparable treatments prove insufficient to normalize blood sugar. Diabex 0.3mg should be ingested immediately prior to meals. Dosage and frequency are determined by your physician to optimize blood sugar control. Abrupt cessation should be avoided without medical consultation, as this may result in dangerously high blood sugar levels and potentially severe complications, such as renal impairment or vision loss. This medication is a component of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as recommended by your doctor. Regular blood glucose monitoring is crucial during treatment. Common adverse effects include gas, abdominal discomfort, anorexia, constipation, and diarrhea. Report any persistent or troubling side effects to your physician. While Diabex 0.3mg alone doesn't typically cause hypoglycemia, its concurrent use with other diabetes medications (especially insulin or sulfonylureas) increases this risk. Hypoglycemic episodes require treatment with pure glucose; sucrose is ineffective. Inform your doctor of any existing kidney or liver conditions before commencing treatment. This medication is contraindicated in individuals with bowel inflammation or ulcers (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating women require medical consultation prior to use. Full disclosure of all other medications is necessary to ensure safety. Limit alcohol consumption, as it can heighten the hypoglycemia risk.
Primary Ingredients of Voligraf 0.3mg Tablet
No text provided to rephrase.
Uses of Voligraf 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Voligraf 0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Voligraf 0.3mg Tablet on an empty stomach.
Common Side effects of Voligraf 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voligraf 0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Swallow the 0.3mg Voligraf tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Voligraf 0.3mg Tablet works:
Glucovance 0.3mg tablets are used to manage diabetes. Their mechanism involves blocking the enzymes in the intestines that digest complex carbohydrates into simpler sugars like glucose, thus moderating post-meal blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voligraf 0.3mg tablets and alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Voligraf 0.3mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals have indicated minimal or absent harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Voligraf 0.3mg tablets safely. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Voligraf 0.3mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Voligraf 0.3mg tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Voligraf 0.3mg tablets. Dosage modification of Voligraf 0.3mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Voligraf 0.3mg Tablet :
Omit any missed Voligraf 0.3mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Voligraf 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |
